Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clevidipine for the Antihypertensive Treatment of Acute Intracerebral Hemorrhage

NCT06402968 is registered in ClinicalTrials.gov with Zeenat Qureshi Stroke Institute as lead sponsor.

NCT NCT06402968
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06402968 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clevidipine for the Antihypertensive Treatment of Acute Intracerebral Hemorrhage
Lead sponsor
Zeenat Qureshi Stroke Institute
Phase
Observational
Overall status
Recruiting
Start date
June 1, 2024
Completion date
July 30, 2028
Enrollment
1,018 (estimated)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

hypertension, intracerebral hemorrhage, stroke